Newsroom | 4789 results

NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the fourth quarter and year ended December 31, 2024. The Company also posted its fourth quarter Letter to Stockholders and corporate presentation to the “Investors” section of its website, harrow.com. The Company encourages all Harrow stockholders to review these documents, which provide additional details concerning the historical quarterly period and future...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its fourth quarter and audited financial results for the year ended December 31, 2024, on Thursday, March 27, 2025, after the market close. The Company will also post its fourth quarter Letter to Stockholders to the “Investors” section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Fri...

BALTIMORE--(BUSINESS WIRE)--Pantheon Vision, a preclinical-stage medical device company developing bioengineered corneal implants to eliminate corneal blindness, today announced entering a collaboration agreement with manufacturer Eyedeal Medical. Under the terms of the agreement, the companies will work to advance the production and commercialization of Pantheon Vision’s bioengineered corneal implant. “Pantheon Vision has assembled a world-leading ophthalmic design team whose groundbreaking mi...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall of intraocular lenses (IOLs) on its enVista platform. This action was taken out of an abundance of caution after the company received reports of complications, the cause of which could not immediately be explained. “As much as we believe in the enVista platform, patient safety will always be o...

GENEVA--(BUSINESS WIRE)--Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease...

GENEVA--(BUSINESS WIRE)--Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease...

ATLANTA--(BUSINESS WIRE)--National Vision Holdings, Inc., a leading optical retail company behind brands like America's Best and Eyeglass World, has appointed VML as its agency of record (AOR) following a competitive review. VML will play a key role in leading National Vision’s brand evolution, redefining National Vision's communication and brand platforms with a focus on creative, CRM, social strategy, brand identity and design, and experiential. The new partnership will support National Visio...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter financial results on Wednesday, April 30, 2025. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of th...

JERSEY CITY, N.J.--(BUSINESS WIRE)--Character Biosciences Raises $93 Million Series B to Advance Precision Medicine for Progressive Eye Diseases...

GENEVA--(BUSINESS WIRE)--Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities...